Answers are grounded in this paper and cite their sources.
A brief overview of the future prospective of phosphodiesterase-3 inhibitors as antithrombotic drugs.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Nishikawa et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: